primarily Lri Vline PRO Filler, Packaging Type : Box

The LRI product line appears to include two distinct types of injectable products distributed by LRI SRO Prague Company: a traditional dermal filler used for cosmetic enhancements, and an injectable product marketed for weight loss (referred to as LRI Pro). 

LRI Dermal Filler

The LRI Filler is a line of hyaluronic acid-based dermal fillers designed to add volume, smooth wrinkles, and enhance facial contours. It is described as a high-quality product meeting European CE standards. 

Composition: Hyaluronic acid-based gel.

Mechanism: Injected under the skin to plump tissue, restore volume, and correct facial contours. The hyaluronic acid binds with water, improving skin elasticity and hydration.

Benefits: Provides soft and smooth injection results with no clumping or swelling, long-lasting effects (12-24 months), and natural appearance.

Varieties: Available in different densities to suit various applications:

Soft: For delicate areas and fine lines.

Ultra: For mid-level corrections.

Volume: For deeper wrinkles and significant contouring (e.g., cheeks, jawline).

Application Areas: Used for lips, nose correction, smoothing deep lines (nasolabial folds), eye rejuvenation, and scar correction. 

LRI Pro Weight Loss Product

The LRI Pro is marketed as an injectable solution for full-body fat reduction and weight management, with some sources referring to it as a "filler" for "fat disposal". 

Mechanism: The product claims to work by mimicking the natural hormone glucagon (similar to GLP-1 receptor agonists like Liraglutide, though specific active ingredients are not consistently listed across all snippets). This action is intended to:

Regulate insulin metabolism and improve insulin resistance.

Increase satiety and inhibit hunger, reducing appetite.

Liquefy stubborn fat tissue for elimination through the excretory system.

Burn fat and increase energy.

Benefits: Advertised as a non-surgical method that can lead to significant weight loss (e.g., 4-8kg per treatment course), minimal side effects (temporary nausea or dizziness during the first week), no downtime, and prevention of fat re-accumulation.

Administration: Administered via injection, often in a series over several weeks, typically once a week.